The ImmuneWatch Logo

We want to unleash the full potential of T cell-based therapeutics and diagnostics.

That is why we are solving the T cell specificity problem using AI

NEW!

Want to try out our ImmuneWatch DETECT tool for annotating TCR-epitope specificity?

We are now open to receive applications for our Early Access Program. We only have a few limited spots available.

The T cell specificity problem is a key challenge in immunology

It refers to the challenge of predicting which specific target a T cell will recognise with its T-cell receptor.

At ImmuneWatch we have always been at the forefront of using AI and immunoinformatics to make predictions about T cell specificity. We use it to improve the development processes of vaccines, therapies and diagnostic applications where T cells play an important role. Get more insights and make better predictions regarding your T cell responses.

Computational biology
Artificial intelligence image

The Team

ImmuneWatch builds upon years of multi-disciplinary collaborations between clinicians and data scientists at the University of Antwerp and Antwerp University Hospital (Belgium).

We have a long scientific publication track-record and extensive expertise in biomolecular data mining, medical artificial intelligence, computational and translational immunology.

Applications of Tcr-EPITOPE prediction models

Prof. Pieter Meysman is an associate professor at the University of Antwerp and co-founder and CTO at ImmuneWatch.

In this seminar, organised by the Adaptive Immune Receptor Repertoire (AIRR) community, Pieter explains the applications of TCR-epitope prediction models and why ImmuneWatch current alogrithms outperform all current other solutions.

Interested? Contact us now for more information, collaborations and partnerships.

Latest News

Partners

Be the first to know:

Business [at] immunewatch.com

Privacy and cookie policy

Copyright © 2021 ImmuneWatch BV. ImmuneWatch is a registered trademark.

ImmuneWatch BV | BE0774.472.942 | Lange Gasthuisstraat 29-31, 2000, Antwerp, Belgium